US Psych Congress 2017

US Psych Congress 2017
The 30th annual Psych Congress, hosted in New Orleans, Louisiana, from September 16-19, 2017, will bring together mental health professionals to discuss ways to improve patient outcomes through emerging research and cutting-edge psychiatric therapies. The Congress' focus on psychopharmacology, psychotherapy, and wellness offers valuable insights for mental health practitioners and other clinicians looking to continue their education. Sign up for our daily e-mail blasts on our registration page, and check back here during the conference for the full coverage.
September 26, 2017
During a presentation at the US Psychiatric and Mental Health Congress in New Orleans, Louisiana, Mark Zimmerman, MD, said studies show that the presence of a comorbid disorder or specific symptom were the most important factors driving treatment decisions when clinicians picked an antidepressant, and anxiety was the symptom they cited most frequently.
September 25, 2017
With so many options for treatment-resistant depression, expert George Papakostas, MD, said all things being equal, the patient's preference counts.
September 20, 2017
Leslie Citrome, MD, MPH, of New York Medical College, discusses payer coverage of atypical antipsychotics with fewer metabolic side effects.
September 19, 2017
A survey of patients with ADHD showed that two-thirds of those who augment their morning medication do so because it stops working, and 42% have to plan their day around their medication fading.
September 19, 2017
There is a stigma that comes with being addicted to opioids, even if they are prescribed to manage pain, that can hurt the care patients need to receive, said Arwen Podesta, MD, ABPN, FASAM, ABIHM, of Tulane University.
September 19, 2017
Payers have made tremendous progress in improving oversight of opioids and other pain medications, but what is really needed is a shift to abuse-deterrent formulations, which are more expensive, said Thomas Kosten, MD, a psychiatrist with Baylor College of Medicine.
September 18, 2017
The debate over marijuana policy tends to be dominated by people with political "skin in the game," when what's needed is a balanced, evidenced-based review, said Kevin P. Hill, MD, MHS, of Beth Israel Deaconess Medical Center and Harvard Medical School.
September 18, 2017
Experts said that the frequency and quality of social relationships have a greater effect on mortality than obesity or drinking alcohol, and this commands attention from health systems.
September 18, 2017
Right now, state policy regarding medical marijuana use is out ahead of the science, which can lead to predicaments where cannabis is prescribed in situations where it is not needed, explained Kevin P. Hill, MD, MHS, of Beth Israel Deaconess Medical Center and Harvard Medical School.
September 18, 2017
Patients with childhood trauma may have reduced response to antidepressant agents, and physician need to be given more free rein to tailor treatment approaches to treat those with major depressive disorder, said Vladimir Maletic, MD, MS, clinical professor of neuropsychiatry and behavioral science at the University of South Carolina School of Medicine.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome to the new and improved, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!